Currently out of the existing stock ratings of Andres Maldonado, 114 are a BUY (96.61%), 4 are a HOLD (3.39%).

Andres Maldonado

Work Performance Price Targets & Ratings Chart

Analyst Andres Maldonado, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 28.42% that have a potential upside of 40.05% achieved within 144 days.

Andres Maldonado’s has documented 242 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on VSTM, Verastem at 24-Jun-2026.

Wall Street Analyst Andres Maldonado

Analyst best performing recommendations are on IBRX (IMMUNITYBIO).
The best stock recommendation documented was for SRRK (SCHOLAR ROCK HOLDING CORP) at 6/25/2024. The price target of $30 was fulfilled within 104 days with a profit of $21.93 (271.75%) receiving and performance score of 26.13.

Average potential price target upside

of $91.75 (60.79%) on STRO (SUTRO BIOPHARMA).
of $45.36 (71.06%) on IKNA (IKENA ONCOLOGY).

AURA Aura Biosciences CADL Candel Therapeutics CRBP Corbus Pharmaceuticals DAWN Day One Biopharmaceuticals ENGN enGene Holdings Common Stock ERAS Erasca FHTX Foghorn Therapeutics IBRX Immunitybio IKNA Ikena Oncology IMAB I-Mab IMNM Immunome MNPR Monopar Therapeutics MURA Mural Oncology plc SNDX Syndax Pharmaceuticals SRRK Scholar Rock Holding Corp STRO Sutro Biopharma TARA Protara Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Andres Maldonado (HC WAINWRIGHT)